Maravai Lifesciences Holdings Inc Market Cap ($1.07 Billion)
Market Cap & Net Worth: Maravai Lifesciences Holdings Inc (MRVI)
Maravai Lifesciences Holdings Inc market cap. Maravai Lifesciences Holdings Inc (NASDAQ:MRVI) has a market capitalization of $1.07 Billion ($1.07 Billion) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8304 globally and #2451 in its home market, demonstrating a -1.78% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Maravai Lifesciences Holdings Inc's stock price $7.19 by its total outstanding shares 148989545 (148.99 Million). Also see cash efficiency ratio of Maravai Lifesciences Holdings Inc for how efficiently the company converts equity into cash flow.
Maravai Lifesciences Holdings Inc Market Cap History (2020–2026)
Maravai Lifesciences Holdings Inc market cap history from 2020 to 2026. Data shows change from $4.18 Billion to $1.07 Billion (-21.27% CAGR). Check latest Maravai Lifesciences Holdings Inc stock price today for real-time trading data and today's change.
Index Memberships
Maravai Lifesciences Holdings Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.04% | #240 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #908 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.83 Trillion | 0.06% | #137 of 263 |
Weight: Maravai Lifesciences Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Maravai Lifesciences Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Maravai Lifesciences Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore MRVI net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.61x
Maravai Lifesciences Holdings Inc's market cap is 2.61 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $4.18 Billion | $284.10 Million | $76.89 Million | 14.71x | 54.35x |
| 2021 | $6.24 Billion | $799.24 Million | $182.04 Million | 7.81x | 34.29x |
| 2022 | $2.13 Billion | $883.00 Million | $220.21 Million | 2.41x | 9.68x |
| 2023 | $975.88 Million | $288.94 Million | -$119.03 Million | 3.38x | N/A |
| 2024 | $811.99 Million | $259.19 Million | -$144.85 Million | 3.13x | N/A |
| 2025 | $484.22 Million | $185.74 Million | -$130.77 Million | 2.61x | N/A |
Competitor Companies of MRVI by Market Capitalization
Companies near Maravai Lifesciences Holdings Inc in the global market cap rankings as of November 4, 2026. Also see how large is Maravai Lifesciences Holdings Inc's balance sheet for a full breakdown of the balance sheet.
Key companies related to Maravai Lifesciences Holdings Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of Maravai Lifesciences Holdings Inc (2020–2026)
Market capitalization of Maravai Lifesciences Holdings Inc from 2020 to today. Between 2020 and today, Maravai Lifesciences Holdings Inc's market cap moved from $4.18 Billion to $ 1.07 Billion, with a yearly change of -21.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.07 Billion | +121.23% |
| 2025 | $484.22 Million | -40.37% |
| 2024 | $811.99 Million | -16.79% |
| 2023 | $975.88 Million | -54.23% |
| 2022 | $2.13 Billion | -65.85% |
| 2021 | $6.24 Billion | +49.38% |
| 2020 | $4.18 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Maravai Lifesciences Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.07 Billion USD |
| MoneyControl | $1.07 Billion USD |
| MarketWatch | $1.07 Billion USD |
| marketcap.company | $1.07 Billion USD |
| Reuters | $1.07 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Maravai Lifesciences Holdings Inc
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products fo… Read more